Joel MBA - Renalytix Interim Officer

Executive

Joel MBA is Interim Officer of Renalytix AI
Age 67
Phone646 397 3970
Webhttps://renalytix.com

Renalytix Management Efficiency

The company has return on total asset (ROA) of (0.9354) % which means that it has lost $0.9354 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.7318) %, meaning that it created substantial loss on money invested by shareholders. Renalytix's management efficiency ratios could be used to measure how well Renalytix manages its routine affairs as well as how well it operates its assets and liabilities.
Renalytix AI currently holds 8.54 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Renalytix AI has a current ratio of 2.43, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Renalytix's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Maxine LiuHealth Catalyst
N/A
Bryant IIIStreamline Health Solutions
49
RN BSNHealthStream
49
Tia PadiaHealthEquity
N/A
Megan CharkoNational Research Corp
N/A
Richard PutnamHealthEquity
N/A
Tarah BryanHealth Catalyst
N/A
Kamesh TumsiHealthEquity
N/A
Allison SwartzProgyny
34
Katie HigginsProgyny
N/A
Jennifer BaronNational Research Corp
N/A
Benjamin LandryHealth Catalyst
42
Daniel OrensteinHealth Catalyst
54
Michael McQuiggHealthStream
57
Adam BrownHealth Catalyst
N/A
Risa FisherProgyny
N/A
Michael CPAForian Inc
63
Wendy LovvornStreamline Health Solutions
51
Bryant ReevesStreamline Health Solutions
N/A
Benjamin StilwillStreamline Health Solutions
36
Rebecca AdamsForian Inc
N/A
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York. Renalytix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people. Renalytix AI (RNLX) is traded on NASDAQ Exchange in USA and employs 9 people.

Management Performance

Renalytix AI Leadership Team

Elected by the shareholders, the Renalytix's board of directors comprises two types of representatives: Renalytix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Renalytix. The board's role is to monitor Renalytix's management team and ensure that shareholders' interests are well served. Renalytix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Renalytix's outside directors are responsible for providing unbiased perspectives on the board's policies.
Oliver III, Chief Officer
Jean Casner, VP Officer
Baljit Singh, Head Operations
Howard Doran, Chief Officer
Salim FCA, Company Secretary
Fergus Fleming, Chief Officer
Andria ParksHerrera, VP Marketing
Joel MBA, Interim Officer
James MBA, Chief Officer

Renalytix Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Renalytix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Renalytix Stock

If you are still planning to invest in Renalytix AI check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Renalytix's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios